We are live on ! Find out more
SCM

Silverarc Capital Management Portfolio holdings

AUM $849M
1-Year Est. Return 470.8%
This Fund
S&P 500
This Quarter Est. Return
+18.72%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$444M
AUM Growth
+$38.7M
Cap. Flow
-$1.93M
Cap. Flow %
-0.43%
Top 10 Hldgs %
47.12%
Holding
80
New
13
Increased
27
Reduced
18
Closed
11

Top Buys

1
INSM icon
Insmed
INSM
+$15.3M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$9.12M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$5.93M
4
VCYT icon
Veracyte
VCYT
+$5.3M
5
PCVX icon
Vaxcyte
PCVX
+$5.23M

Top Sells

1
MORF
Morphic Holding, Inc. Common Stock
MORF
+$16.6M
2
CRBP icon
Corbus Pharmaceuticals
CRBP
+$8.83M
3
CLDX icon
Celldex Therapeutics
CLDX
+$8.76M
4
NUVL icon
Nuvalent
NUVL
+$7.82M
5
URGN icon
UroGen Pharma
URGN
+$2.98M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVL icon
1
Nuvalent
NUVL
$9.81B
$38M 8.56%
371,441
-94,269
-20% -$7.82M
MRUS
2
DELISTED
Merus
MRUS
$31.7M 7.15%
635,439
+11,811
+2% +$617K
INSM icon
3
Insmed
INSM
$23.9B
$25.4M 5.72%
347,695
+207,695
+148% +$15.3M
RNAM
4
DELISTED
Avidity Biosciences
RNAM
$21.8M 4.92%
475,555
-42,179
-8% -$1.83M
ERAS icon
5
Erasca
ERAS
$6.06B
$19M 4.27%
6,946,488
-870,438
-11% -$2.45M
AKRO
6
DELISTED
Akero Therapeutics
AKRO
$18.4M 4.14%
639,840
+14,753
+2% +$385K
VCYT icon
7
Veracyte
VCYT
$4.52B
$16M 3.61%
470,565
+188,317
+67% +$5.3M
RYTM icon
8
Rhythm Pharmaceuticals
RYTM
$7.54B
$13.4M 3.02%
255,578
+70,916
+38% +$3.4M
COGT icon
9
Cogent Biosciences
COGT
$6.58B
$13.2M 2.97%
1,221,362
+15,148
+1% +$147K
ITCI
10
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$12.2M 2.76%
167,110
-25,235
-13% -$1.9M
CNTA
11
DELISTED
Centessa Pharmaceuticals
CNTA
$11.9M 2.68%
+744,592
New +$9.12M
URGN icon
12
UroGen Pharma
URGN
$1.91B
$11.4M 2.58%
901,129
-200,871
-18% -$2.98M
ORIC icon
13
Oric Pharmaceuticals
ORIC
$1.09B
$11.3M 2.54%
1,099,490
+23,678
+2% +$234K
PSTX
14
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$10.5M 2.38%
3,687,548
+79,549
+2% +$246K
VRNA
15
DELISTED
Verona Pharma
VRNA
$10M 2.26%
348,866
+44,233
+15% +$1.09M
ALNY icon
16
Alnylam Pharmaceuticals
ALNY
$37.6B
$9.84M 2.22%
35,774
-226
-0.6% -$58.8K
GERN icon
17
Geron
GERN
$885M
$8.18M 1.84%
1,801,561
+802,291
+80% +$3.65M
SNDX icon
18
Syndax Pharmaceuticals
SNDX
$2.14B
$7.29M 1.64%
378,746
+8,746
+2% +$181K
PCVX icon
19
Vaxcyte
PCVX
$8.12B
$6.91M 1.56%
60,500
+58,000
+2,320% +$5.23M
KALV
20
DELISTED
KalVista Pharmaceuticals
KALV
$6.65M 1.5%
574,558
+13,675
+2% +$172K
PTGX icon
21
Protagonist Therapeutics
PTGX
$8.44B
$6.6M 1.49%
+146,657
New +$5.93M
CCCC icon
22
C4 Therapeutics
CCCC
$421M
$6.54M 1.47%
1,147,891
-294,950
-20% -$1.78M
SRPT icon
23
Sarepta Therapeutics
SRPT
$1.9B
$6.4M 1.44%
51,245
+9,245
+22% +$1.28M
BDSX icon
24
Biodesix
BDSX
$219M
$6.34M 1.43%
178,055
+87,607
+97% +$3.01M
ELUT icon
25
Elutia
ELUT
$40.3M
$6.27M 1.41%
1,645,808
+42,228
+3% +$165K
1
2 3 4

Similar funds

BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
EFG
Embree Financial Group Chicago, Illinois $849M AUM 19.63% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $848M AUM 21.32% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
CFP
Catalyst Financial Partners Boston, Massachusetts $847M AUM 29.19% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $846M AUM 32.1% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return